Nazovin

Nazovin is a nasal decongestant containing the active ingredient xylometazoline hydrochloride, a small molecule alpha-adrenergic receptor agonist. It is indicated for the temporary relief of nasal congestion associated with the common cold, sinusitis, and otitis media. By stimulating alpha-adrenergic receptors in the nasal mucosa, Nazovin induces local vasoconstriction, which reduces swelling and improves airflow. The onset of action occurs within 5 to 10 minutes, with effects lasting up to 10 hours. The product is available in adult metered-dose nasal spray (1 mg/ml) and pediatric nasal drop (0.5 mg/ml) formulations. Originally marketed by Actor Pharma, the brand is now part of the Cipla Medpro South Africa portfolio following the acquisition of Actor Pharma in 2024.

Brand names

Nazovin

Other names

xylometazoline hydrochloride